In this podcast, Dr Dermot Neely and Dr Jai Cegla discuss a recently published joint statement by HEART UK and the Association for Laboratory Medicine about standardising lipid testing and reporting in the United Kingdom, with a particular focus on lipoprotein(a).
COVID-19, and specifically long COVID, is associated with an increased risk of cardiovascular disease. Listen as Amitava Banerjee describes his work in this area, especially the STIMULATE-ICP trial, which looks at long COVID’s physiological and social impact. Find out about what the NHS is doing to tackle COVID-19 and its associated cardiovascular and metabolic abnormalities.
Listen to Terry McCormack and Rani Khatib as they provide a summary of their webinar presentation which discusses updates to the lipid management guidelines for reducing the risk of cardiovascular disease, and the implications for clinical practice.